Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Baxter
Fish and Richardson
Johnson and Johnson
Citi
US Department of Justice
Federal Trade Commission
Express Scripts
Argus Health

Generated: August 18, 2018

DrugPatentWatch Database Preview

Aaa Usa Inc Company Profile

« Back to Dashboard

What is the competitive landscape for AAA USA INC, and when can generic versions of AAA USA INC drugs launch?

AAA USA INC has two approved drugs.

There is one US patent protecting AAA USA INC drugs.

There are twenty-one patent family members on AAA USA INC drugs in eighteen countries.

Summary for Aaa Usa Inc
International Patents:21
US Patents:1
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Aaa Usa Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aaa Usa Inc NETSPOT gallium dotatate ga-68 POWDER;INTRAVENOUS 208547-001 Jun 1, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up
Aaa Usa Inc LUTATHERA lutetium dotatate lu-177 SOLUTION;IV (INFUSION) 208700-001 Jan 26, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up
Aaa Usa Inc LUTATHERA lutetium dotatate lu-177 SOLUTION;IV (INFUSION) 208700-001 Jan 26, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up
Aaa Usa Inc NETSPOT gallium dotatate ga-68 POWDER;INTRAVENOUS 208547-001 Jun 1, 2016 RX Yes Yes 9,375,498 ➤ Sign Up Y ➤ Sign Up
Aaa Usa Inc NETSPOT gallium dotatate ga-68 POWDER;INTRAVENOUS 208547-001 Jun 1, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Non-Orange Book US Patents for Aaa Usa Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,907,868 Process for the preparation of complexes of .sup.68Ga ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Julphar
UBS
Express Scripts
McKinsey
Cipla
Baxter
Citi
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.